comparemela.com

Latest Breaking News On - Biovie inc stock exchange - Page 1 : comparemela.com

BioVie : Sales Agreement - Form 8-K | MarketScreener

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13. | April 7, 2023

United statesCarson citySherman howardJoanne wendy kimSecurities exchangeCompany classExchange commission onCantor fitzgerald coNasdaq stock marketB riley securities incBiovie incCommission file numberExact nameIts charterNye lanesuitePrincipal executive offices

BioVie Announces Additional Findings from Phase 2 Alzheimer s Disease Trial: NE3107 Appears to Impact Biomarkers of Aging-Related Disease States in Addition to Observed Reversal of Cognitive Decline in Dementia

CARSON CITY, Nev., Dec. 06, 2022 BioVie Inc., a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders and advanced. | December 6, 2022

San franciscoUnited statesCampisij gerontolSteven horvathDennis consorteJoseph palumboOberdoerfferp natBruce mackleMoorel neuropsychopharmacologyPublic press relations inquiriesField school of public healthLifesci advisorsDavid geffen school of medicineNucleic acids researchBiovie incGlobenewswire inc

BioVie Announces Patent Issuance Covering Ascites Treatment with BIV201

CARSON CITY, Nev., June 23, 2022 BioVie Inc. , a clinical-stage company developing innovative drug therapies for the treatment of advanced liver disease and neurological and. | June 23, 2022

United statesSouth koreaBruce mackleLifesci advisorsBiovie or companyVeterans administrationBiovie incUs patent trademark officeGlobenewswire incInter partes reviewInvestor relations inquiriesSci advisorsBiovie inc stock exchangePress releaseEurological bivi us09074f2074

vimarsana © 2020. All Rights Reserved.